Brief: Xencor To Receive $105 Million From Alexion To Resolve Ultomiris® U.S. Royalty Matter
29/07/2026 21:21
BRIEF-Xencor To Receive $105 Million From Alexion To Resolve Ultomiris® U.S. Royalty Matter July 29 (Reuters) - Xencor Inc XNCR.O:
XENCOR TO RECEIVE $105 MILLION FROM ALEXION TO RESOLVE ULTOMIRIS® U.S. ROYALTY MATTER
XENCOR - FIRST $52.50 MILLION PAYMENT EXPECTED AUGUST 2026; SECOND PAYMENT DUE ONE YEAR LATER
XENCOR - TO CONTINUE RECEIVING ROYALTIES ON EX-U.S. ULTOMIRIS SALES
Source text: ID:nBw59f9lVa
Further company coverage: XNCR.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Xencor
See all newsXencor, Inc. reports results for the quarter ended June 30 - Earnings Summary
Biopharma firm Xencor's Q2 revenue beats on royalty revenue, milestone payments
Brief: Xencor Q2 EPS USD -0.29
Brief: Xencor To Receive $105 Million From Alexion To Resolve Ultomiris® U.S. Royalty Matter
Xencor Q1 revenue falls sharply and misses estimates